Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1T | 2.6T | 2.3T | 2.7T |
Cost of revenue | 1.8T | 2.1T | 2.0T | 2.3T |
Gross profit | 294.0B | 442.3B | 333.7B | 396.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 136.7B | 37.2B | 32.7B | 32.1B |
Other operating expenses | — | 164.5B | -11.2B | 3.9B |
Operating income | 294.0B | 133.9B | 215.3B | 260.2B |
Non operating interest income | ||||
Income | — | 20.7B | 14.9B | 11.1B |
Expense | — | 1.4B | 2.6B | 4.8B |
Other income expense | — | — | — | — |
Pretax income | 204.6B | 171.3B | 220.0B | 292.9B |
Tax provision | 47.4B | 60.3B | 61.8B | 87.7B |
Net income | 157.2B | 111.0B | 158.2B | 205.3B |
Basic EPS | 768.3 | — | 835 | 1.6K |
Diluted EPS | 768.3 | — | 835 | 1.6K |
Basic average shares | — | — | 196.0M | 196.0M |
Diluted average shares | — | — | 196.0M | 196.0M |
EBITDA | 294.0B | 254.4B | 226.0B | 341.6B |
Net income from continuing op. | — | 111.0B | 158.2B | 205.3B |
Minority interests | -6.6B | 4.9B | 5.4B | 110.1B |
Preferred stock dividends | — | — | — | — |